Brief: Eloxx Pharmaceuticals Inc Reports Q3 Loss Per Share Of $0.09

Eloxx Pharmaceuticals

10/11/2022 22:53

Nov 10 (Reuters) - Eloxx Pharmaceuticals Inc  ELOX.O :
    * ELOXX PHARMACEUTICALS REPORTS THIRD QUARTER 2022 FINANCIAL
AND
OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
    * ELOXX PHARMACEUTICALS INC Q3 LOSS PER SHARE $0.09

Source text for Eikon:  ID:nGNX25W1Sk 
Further company coverage:  ELOX.O 
 ((Reuters.Briefs@thomsonreuters.com;;))